{"id":"https://openalex.org/W2601428988","doi":"https://doi.org/10.1021/acs.jmedchem.7b00055","title":"Development of a Series of Kynurenine 3-Monooxygenase Inhibitors Leading to a Clinical Candidate for the Treatment of Acute Pancreatitis","display_name":"Development of a Series of Kynurenine 3-Monooxygenase Inhibitors Leading to a Clinical Candidate for the Treatment of Acute Pancreatitis","publication_year":2017,"publication_date":"2017-03-28","ids":{"openalex":"https://openalex.org/W2601428988","doi":"https://doi.org/10.1021/acs.jmedchem.7b00055","mag":"2601428988","pmid":"https://pubmed.ncbi.nlm.nih.gov/28398044"},"language":"en","primary_location":{"id":"doi:10.1021/acs.jmedchem.7b00055","doi":"https://doi.org/10.1021/acs.jmedchem.7b00055","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.7b00055","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.research.ed.ac.uk/en/publications/7e159ac4-ec5c-440a-88b9-734f41143ab2","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040689242","display_name":"Ann L. Walker","orcid":"https://orcid.org/0000-0002-1027-2099","observed_orcids":["https://orcid.org/0000-0002-1027-2099"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Ann L. Walker","raw_affiliation_strings":["Discovery\rPartnerships with Academia, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, UK"],"raw_orcid":"https://orcid.org/0000-0002-1027-2099","affiliations":[{"raw_affiliation_string":"Discovery\rPartnerships with Academia, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062258773","display_name":"Nicolas Ancellin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101023","display_name":"GlaxoSmithKline (France)","ror":"https://ror.org/00z1h3j87","country_code":"FR","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210101023"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nicolas Ancellin","raw_affiliation_strings":["Flexible\rDiscovery Unit, GlaxoSmithKline, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Flexible\rDiscovery Unit, GlaxoSmithKline, Paris, France","institution_ids":["https://openalex.org/I4210101023"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007710082","display_name":"Benjamin Beaufils","orcid":"https://orcid.org/0000-0002-9965-0251","observed_orcids":["https://orcid.org/0000-0002-9965-0251"]},"institutions":[{"id":"https://openalex.org/I4210101023","display_name":"GlaxoSmithKline (France)","ror":"https://ror.org/00z1h3j87","country_code":"FR","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210101023"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Benjamin Beaufils","raw_affiliation_strings":["Flexible\rDiscovery Unit, GlaxoSmithKline, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Flexible\rDiscovery Unit, GlaxoSmithKline, Paris, France","institution_ids":["https://openalex.org/I4210101023"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008495056","display_name":"Marylise Bergeal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Marylise Bergeal","raw_affiliation_strings":["Platform\rTechnology Sciences, GlaxoSmithKline Stevenage SG1 2NY, UK",") Platform Technology Sciences, GSK: d) Centre for Cardiovascular Science, University of Edinburgh:"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Platform\rTechnology Sciences, GlaxoSmithKline Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":") Platform Technology Sciences, GSK: d) Centre for Cardiovascular Science, University of Edinburgh:","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016597666","display_name":"Margaret Binnie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Margaret Binnie","raw_affiliation_strings":["Centre\rfor Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4TJ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre\rfor Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4TJ, UK","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073815852","display_name":"Anne Bouillot","orcid":"https://orcid.org/0000-0002-7433-5714","observed_orcids":["https://orcid.org/0000-0002-7433-5714"]},"institutions":[{"id":"https://openalex.org/I4210101023","display_name":"GlaxoSmithKline (France)","ror":"https://ror.org/00z1h3j87","country_code":"FR","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210101023"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Anne Bouillot","raw_affiliation_strings":["Flexible\rDiscovery Unit, GlaxoSmithKline, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Flexible\rDiscovery Unit, GlaxoSmithKline, Paris, France","institution_ids":["https://openalex.org/I4210101023"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032905214","display_name":"David Clapham","orcid":"https://orcid.org/0000-0003-3075-7621","observed_orcids":["https://orcid.org/0000-0003-3075-7621"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David Clapham","raw_affiliation_strings":["Platform\rTechnology Sciences, GlaxoSmithKline Stevenage SG1 2NY, UK",") Platform Technology Sciences, GSK: d) Centre for Cardiovascular Science, University of Edinburgh:"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Platform\rTechnology Sciences, GlaxoSmithKline Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":") Platform Technology Sciences, GSK: d) Centre for Cardiovascular Science, University of Edinburgh:","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084718951","display_name":"Alexis Denis","orcid":"https://orcid.org/0000-0002-1058-7517","observed_orcids":["https://orcid.org/0000-0002-1058-7517"]},"institutions":[{"id":"https://openalex.org/I4210101023","display_name":"GlaxoSmithKline (France)","ror":"https://ror.org/00z1h3j87","country_code":"FR","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210101023"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Alexis Denis","raw_affiliation_strings":["Flexible\rDiscovery Unit, GlaxoSmithKline, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Flexible\rDiscovery Unit, GlaxoSmithKline, Paris, France","institution_ids":["https://openalex.org/I4210101023"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079811108","display_name":"Carl P. Haslam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Carl P. Haslam","raw_affiliation_strings":["Platform\rTechnology Sciences, GlaxoSmithKline Stevenage SG1 2NY, UK",") Platform Technology Sciences, GSK: d) Centre for Cardiovascular Science, University of Edinburgh:"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Platform\rTechnology Sciences, GlaxoSmithKline Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":") Platform Technology Sciences, GSK: d) Centre for Cardiovascular Science, University of Edinburgh:","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083365899","display_name":"Duncan S. Holmes","orcid":"https://orcid.org/0000-0002-7958-8606","observed_orcids":["https://orcid.org/0000-0002-7958-8606"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Duncan S. Holmes","raw_affiliation_strings":["Discovery\rPartnerships with Academia, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery\rPartnerships with Academia, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083411419","display_name":"Jonathan P. Hutchinson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jonathan P. Hutchinson","raw_affiliation_strings":["Platform\rTechnology Sciences, GlaxoSmithKline Stevenage SG1 2NY, UK",") Platform Technology Sciences, GSK: d) Centre for Cardiovascular Science, University of Edinburgh:"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Platform\rTechnology Sciences, GlaxoSmithKline Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":") Platform Technology Sciences, GSK: d) Centre for Cardiovascular Science, University of Edinburgh:","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090516984","display_name":"John Liddle","orcid":"https://orcid.org/0000-0003-1805-3728","observed_orcids":["https://orcid.org/0000-0003-1805-3728"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"John Liddle","raw_affiliation_strings":["Discovery\rPartnerships with Academia, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery\rPartnerships with Academia, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110522369","display_name":"Andrew McBride","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andrew McBride","raw_affiliation_strings":["Centre\rfor Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4TJ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre\rfor Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4TJ, UK","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061526504","display_name":"Olivier Mirguet","orcid":"https://orcid.org/0000-0002-5486-0386","observed_orcids":["https://orcid.org/0000-0002-5486-0386"]},"institutions":[{"id":"https://openalex.org/I4210101023","display_name":"GlaxoSmithKline (France)","ror":"https://ror.org/00z1h3j87","country_code":"FR","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210101023"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Olivier Mirguet","raw_affiliation_strings":["Flexible\rDiscovery Unit, GlaxoSmithKline, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Flexible\rDiscovery Unit, GlaxoSmithKline, Paris, France","institution_ids":["https://openalex.org/I4210101023"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108693308","display_name":"Christopher G. Mowat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Christopher G. Mowat","raw_affiliation_strings":["EastChem\rSchool of Chemistry, University of Edinburgh, Edinburgh EH9 3FJ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EastChem\rSchool of Chemistry, University of Edinburgh, Edinburgh EH9 3FJ, UK","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089105481","display_name":"Paul Rowland","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Paul Rowland","raw_affiliation_strings":["Platform\rTechnology Sciences, GlaxoSmithKline Stevenage SG1 2NY, UK",") Platform Technology Sciences, GSK: d) Centre for Cardiovascular Science, University of Edinburgh:"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Platform\rTechnology Sciences, GlaxoSmithKline Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":") Platform Technology Sciences, GSK: d) Centre for Cardiovascular Science, University of Edinburgh:","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004700441","display_name":"Nathalie Tiberghien","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101023","display_name":"GlaxoSmithKline (France)","ror":"https://ror.org/00z1h3j87","country_code":"FR","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210101023"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nathalie Tiberghien","raw_affiliation_strings":["Flexible\rDiscovery Unit, GlaxoSmithKline, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Flexible\rDiscovery Unit, GlaxoSmithKline, Paris, France","institution_ids":["https://openalex.org/I4210101023"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053890371","display_name":"Lionel Trottet","orcid":"https://orcid.org/0000-0002-1535-6806","observed_orcids":["https://orcid.org/0000-0002-1535-6806"]},"institutions":[{"id":"https://openalex.org/I4210101023","display_name":"GlaxoSmithKline (France)","ror":"https://ror.org/00z1h3j87","country_code":"FR","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210101023"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Lionel Trottet","raw_affiliation_strings":["Flexible\rDiscovery Unit, GlaxoSmithKline, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Flexible\rDiscovery Unit, GlaxoSmithKline, Paris, France","institution_ids":["https://openalex.org/I4210101023"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035814043","display_name":"Iain Uings","orcid":"https://orcid.org/0000-0001-8313-4685","observed_orcids":["https://orcid.org/0000-0001-8313-4685"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Iain Uings","raw_affiliation_strings":["Discovery\rPartnerships with Academia, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery\rPartnerships with Academia, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018561796","display_name":"Scott Peter Webster","orcid":"https://orcid.org/0000-0003-4656-4744","observed_orcids":["https://orcid.org/0000-0003-4656-4744"]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Scott P. Webster","raw_affiliation_strings":["Centre\rfor Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4TJ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre\rfor Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4TJ, UK","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106439331","display_name":"Xiaozhong Zheng","orcid":"https://orcid.org/0009-0005-6065-8853","observed_orcids":["https://orcid.org/0009-0005-6065-8853","https://orcid.org/0000-0002-9803-9688","https://orcid.org/0009-0001-5423-6065"]},"institutions":[{"id":"https://openalex.org/I4210151647","display_name":"Centre for Inflammation Research","ror":"https://ror.org/05wcr1b38","country_code":"GB","type":"facility","lineage":["https://openalex.org/I4210087105","https://openalex.org/I4210151647","https://openalex.org/I90344618","https://openalex.org/I98677209"]},{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Xiaozhong Zheng","raw_affiliation_strings":["MRC Centre\rfor Inflammation Research, University of Edinburgh, Edinburgh EH16 4TJ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Centre\rfor Inflammation Research, University of Edinburgh, Edinburgh EH16 4TJ, UK","institution_ids":["https://openalex.org/I4210151647","https://openalex.org/I98677209"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032440666","display_name":"Damian J. Mole","orcid":"https://orcid.org/0000-0001-6884-7302","observed_orcids":["https://orcid.org/0000-0001-6884-7302"]},"institutions":[{"id":"https://openalex.org/I4210151647","display_name":"Centre for Inflammation Research","ror":"https://ror.org/05wcr1b38","country_code":"GB","type":"facility","lineage":["https://openalex.org/I4210087105","https://openalex.org/I4210151647","https://openalex.org/I90344618","https://openalex.org/I98677209"]},{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Damian J. Mole","raw_affiliation_strings":["MRC Centre\rfor Inflammation Research, University of Edinburgh, Edinburgh EH16 4TJ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Centre\rfor Inflammation Research, University of Edinburgh, Edinburgh EH16 4TJ, UK","institution_ids":["https://openalex.org/I4210151647","https://openalex.org/I98677209"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5040689242"],"corresponding_institution_ids":["https://openalex.org/I188950975"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":3.6268,"has_fulltext":false,"cited_by_count":37,"citation_normalized_percentile":{"value":0.92724738,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":99},"biblio":{"volume":"60","issue":"8","first_page":"3383","last_page":"3404"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10760","display_name":"Pancreatitis Pathology and Treatment","score":0.8047000169754028,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10760","display_name":"Pancreatitis Pathology and Treatment","score":0.8047000169754028,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11337","display_name":"Tryptophan and brain disorders","score":0.021900000050663948,"subfield":{"id":"https://openalex.org/subfields/2803","display_name":"Biological Psychiatry"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.01510000042617321,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kynurenine-3-monooxygenase","display_name":"kynurenine 3-monooxygenase","score":0.9729999899864197},{"id":"https://openalex.org/keywords/acute-pancreatitis","display_name":"acute pancreatitis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.652999997138977},{"id":"https://openalex.org/keywords/water-solubility","display_name":"water solubility","score":0.9150000214576721},{"id":"https://openalex.org/keywords/intravenous-administration","display_name":"intravenous administration","score":0.9440000057220459},{"id":"https://openalex.org/keywords/lung-injury","display_name":"lung injury","score":0.42500001192092896},{"id":"https://openalex.org/keywords/kidney-injury","display_name":"kidney injury","score":0.953000009059906},{"id":"https://openalex.org/keywords/huntington-s-disease","display_name":"Huntington's disease","score":0.6159999966621399}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.794711709022522},{"id":"https://openalex.org/C2776670229","wikidata":"https://www.wikidata.org/wiki/Q854573","display_name":"Acute pancreatitis","level":2,"score":0.6955733299255371},{"id":"https://openalex.org/C13002179","wikidata":"https://www.wikidata.org/wiki/Q6901821","display_name":"Monooxygenase","level":4,"score":0.6270109415054321},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6144893169403076},{"id":"https://openalex.org/C2775967933","wikidata":"https://www.wikidata.org/wiki/Q1527888","display_name":"Pancreatitis","level":2,"score":0.5737341642379761},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.4198969602584839},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2843455970287323},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.28415489196777344},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.24637570977210999},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19518578052520752},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.16592714190483093},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.12413915991783142}],"mesh":[{"descriptor_ui":"D000208","descriptor_name":"Acute Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010195","descriptor_name":"Pancreatitis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D050601","descriptor_name":"Kynurenine 3-Monooxygenase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1021/acs.jmedchem.7b00055","doi":"https://doi.org/10.1021/acs.jmedchem.7b00055","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.7b00055","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:28398044","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28398044","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"},{"id":"pmh:oai:pure.ed.ac.uk:openaire/7e159ac4-ec5c-440a-88b9-734f41143ab2","doi":null,"is_oa":true,"landing_page_url":"https://www.research.ed.ac.uk/en/publications/7e159ac4-ec5c-440a-88b9-734f41143ab2","pdf_url":null,"source":{"id":"https://openalex.org/S4306400321","display_name":"Edinburgh Research Explorer (University of Edinburgh)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I98677209","host_organization_name":"University of Edinburgh","host_organization_lineage":["https://openalex.org/I98677209"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Walker, A L, Ancellin, N, Beaufils, B, Bergeal, M, Binnie, M, Clapham, D, Haslam, C P, Holmes, D S, Hutchinson, J P, Liddle, J, McBride, A, Mirguet, O, Mowat, C G, Rowland, P, Tiberghien, N, Trottet, L, Uings, I, Webster, S P, Zheng, X & Mole, D J 2017, 'Development of a Series of Kynurenine 3-Monooxygenase Inhibitors Leading to a Clinical Candidate for the Treatment of Acute Pancreatitis', Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.7b00055","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:pure.ed.ac.uk:openaire/7e159ac4-ec5c-440a-88b9-734f41143ab2","doi":null,"is_oa":true,"landing_page_url":"https://www.research.ed.ac.uk/en/publications/7e159ac4-ec5c-440a-88b9-734f41143ab2","pdf_url":null,"source":{"id":"https://openalex.org/S4306400321","display_name":"Edinburgh Research Explorer (University of Edinburgh)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I98677209","host_organization_name":"University of Edinburgh","host_organization_lineage":["https://openalex.org/I98677209"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Walker, A L, Ancellin, N, Beaufils, B, Bergeal, M, Binnie, M, Clapham, D, Haslam, C P, Holmes, D S, Hutchinson, J P, Liddle, J, McBride, A, Mirguet, O, Mowat, C G, Rowland, P, Tiberghien, N, Trottet, L, Uings, I, Webster, S P, Zheng, X & Mole, D J 2017, 'Development of a Series of Kynurenine 3-Monooxygenase Inhibitors Leading to a Clinical Candidate for the Treatment of Acute Pancreatitis', Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.7b00055","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7463322454","display_name":"Premature death and organ hypofunction after severe acute pancreatitis results from cellular senescence - mechanisms and new opportunities for therapy","funder_award_id":"MR/P008887/1","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"}],"funders":[{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320320241","display_name":"Academy of Medical Sciences","ror":"https://ror.org/00c489v88"},{"id":"https://openalex.org/F4320320265","display_name":"Health Foundation","ror":"https://ror.org/02bzj4420"},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1560861064","https://openalex.org/W1948607896","https://openalex.org/W1965745121","https://openalex.org/W1968870932","https://openalex.org/W1973734061","https://openalex.org/W1983052331","https://openalex.org/W2054921486","https://openalex.org/W2083528601","https://openalex.org/W2134002465","https://openalex.org/W2167297344","https://openalex.org/W2169394217","https://openalex.org/W2176695138","https://openalex.org/W2234524284","https://openalex.org/W2344300359","https://openalex.org/W2441327331","https://openalex.org/W2560793768","https://openalex.org/W2592651361","https://openalex.org/W2622144515","https://openalex.org/W2950881670"],"related_works":["https://openalex.org/W2427040778","https://openalex.org/W2622144515","https://openalex.org/W2592651361","https://openalex.org/W2234524284","https://openalex.org/W3150168528","https://openalex.org/W3088434753","https://openalex.org/W2176695138","https://openalex.org/W4205213916","https://openalex.org/W771551259","https://openalex.org/W2526153451"],"abstract_inverted_index":{"Recently,":[0],"we":[1],"reported":[2,41],"a":[3,70,100],"novel":[4,71],"role":[5],"for":[6,30,35],"KMO":[7,76],"in":[8,63,91,99],"the":[9,39,57],"pathogenesis":[10],"of":[11,17,19,73,103],"acute":[12,104],"pancreatitis":[13],"(AP).":[14],"A":[15],"number":[16],"inhibitors":[18,40,77],"kynurenine":[20],"3-monooxygenase":[21],"(KMO)":[22],"have":[23,44,66],"previously":[24],"been":[25],"described":[26],"as":[27],"potential":[28],"treatments":[29],"neurodegenerative":[31],"conditions":[32],"and":[33,68,96,106],"particularly":[34],"Huntington's":[36],"disease.":[37],"However,":[38],"to":[42,49,53],"date":[43],"insufficient":[45],"aqueous":[46],"solubility":[47],"relative":[48],"their":[50],"cellular":[51],"potency":[52],"be":[54],"compatible":[55],"with":[56,78],"intravenous":[58],"(iv)":[59],"dosing":[60],"route":[61],"required":[62],"AP.":[64],"We":[65],"identified":[67],"optimized":[69],"series":[72],"high":[74],"affinity":[75],"favorable":[79],"physicochemical":[80],"properties.":[81],"The":[82],"leading":[83],"example":[84],"is":[85,107],"exquisitely":[86],"selective,":[87],"has":[88],"low":[89],"clearance":[90],"two":[92],"species,":[93],"prevents":[94],"lung":[95],"kidney":[97],"damage":[98],"rat":[101],"model":[102],"pancreatitis,":[105],"progressing":[108],"into":[109],"preclinical":[110],"development.":[111]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-04-07T00:00:00"}